1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow macitentan 10 mg: new trials by email Literature Review of macitentan 10 mg trials Research Report on macitentan 10 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease macitentan 10 mg - Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease | Phase 2 | Terminated | Actelion | 91 | 2018-12-07 | 2025-02-04 |
Actelion (1)
Argentina (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Poland (1) · Romania (1) · Russia (1) · Sweden (1) · United Kingdom (1) · United States (1)
William Byra, MD (1)
2018 (1)